Show simple item record

Nine versus52 weeks of adjuvant trastuzumab in early breast cancer:An observational study of the Turkısh Oncology Group

dc.contributor.authorSAİP, PINAR MUALLA
dc.date.accessioned2021-03-03T14:23:53Z
dc.date.available2021-03-03T14:23:53Z
dc.identifier.citationSAİP P. M. , "Nine versus52 weeks of adjuvant trastuzumab in early breast cancer:An observational study of the Turkısh Oncology Group", JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, Amerika Birleşik Devletleri, 20 Mayıs 2011, cilt.29, sa.15, ss.629
dc.identifier.othervv_1032021
dc.identifier.otherav_3947cbea-fe32-457a-9eab-6db799245e9d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/42526
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.titleNine versus52 weeks of adjuvant trastuzumab in early breast cancer:An observational study of the Turkısh Oncology Group
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , Onkoloji Enstitüsü , Onkoloji Enstitüsü
dc.identifier.volume29
dc.contributor.firstauthorID340407


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record